Discriminative stimulus properties of hallucinogens and related designer drugs (1991) - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > CHEMICAL & (SEMI-) SYNTHETIC DRUGS > Research Chemicals
Register Tags Mark Forums Read

Notices

Research Chemicals Piperazines, Phenethylamines, Tryptamines & other Research Chemicals or designer drugs.

Reply
 
Thread Tools Display Modes
  #1  
Old 27-01-2008, 10:39
Jatelka's Avatar
Jatelka Jatelka is offline
Jatelka is back in a funk: The weekend aint so great!
Psychedelic Shepherdess
Moderator
 
Join Date: 16-10-2005
Location: United Kingdom
Age: 33
Posts: 5,025
Jatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond repute
Points: 18,048, Level: 19 Points: 18,048, Level: 19 Points: 18,048, Level: 19
Activity: 46% Activity: 46% Activity: 46%
Discriminative stimulus properties of hallucinogens and related designer drugs (1991)

A new entry has been added to Drugs Archive

Description:
NIDA Res Monogr. 1991;(116):25-44

Glennon RA.

Animals trained to discriminate classical hallucinogens from saline have been used in the past decade to examine other hallucinogenic agents. Time course (onset, duration of action) and locus of action have been studied, SARs have been formulated, and mechanism of action has been investigated in detail. On the basis of DD studies in animals, it was proposed that hallucinogenic agents may produce their actions in humans via a 5-HT2 agonist mechanism and that certain phenalkylamine hallucinogens such as DOM and DOB might constitute the first known examples of 5-HT2 agonists. This led to the development of [3]HDOB and [125I]DOI for use in radioligand binding and autoradiographic studies and to the use of hallucinogen-trained animals as a functional behavioral model of 5-HT2 receptor activation. Animals trained to classical hallucinogens are more recently being used to evaluate novel designer drugs. It can be seen, then, that this paradigm, using hallucinogenic agents as training drugs, has proven to be quite useful for the investigation of hallucinogens and nonhallucinogens alike.

To check it out, rate it or add comments, visit Discriminative stimulus properties of hallucinogens and related designer drugs (1991)
The comments you make there will appear in the posts below.
Reply With Quote
Reply

Bookmarks

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Opinions - Drugs and Crime Go Hand in Hand Police Officer Drug Policy Reform & Narco Politics 214 12-07-2009 18:24
Interesting scholarly drug facts rxbandit Pharmacology 17 30-10-2008 06:53
Fentanyl Designer Drugs: Past History and Future Prospects 0utrider Opium, Opiates & Opioids 0 25-08-2007 15:38


Sitelinks: Site Functions:

All times are GMT +1. The time now is 13:42.


Copyright: Substance Information Network 2003 - 2009, All rights reserved